WES analysis revealed a TP53 mutation ( nM_000546.4:c.713G>A, p.(Cys238Tyr)) with an allele frequency of 69% and 98% in metastatic orbital metastasis and lymph node metastasis, respectively. Here, TP53 is linked to metastatic malignant neoplasm in the lymph nodes.